Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Economic Evaluations of Medication Safety Interventions in Primary and Long-Term Care: A Systematic Review.

Amritlal ST. et al, (2026), Pharmacoeconomics, 44, 299 - 316

Economic evaluations in the palliative and end-of-life care settings: A systematic review of existing evidence, methods and quality.

Fischer C. et al, (2026), Palliat Med

Follow-up of suspected child maltreatment cases treated at a tertiary child protection service facility.

Mora-Theuer EA. et al, (2026), Eur J Pediatr, 185

Towards a Multi-sectoral Approach to Population Health: A Scoping Review of Cross-sectoral Evaluations of Health Interventions.

Koleva-Kolarova R. et al, (2026), Appl Health Econ Health Policy

Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania.

Jiang J. et al, (2026), BMC Med

Influence of stage at cancer diagnosis on NHS hospital care costs in England: a national, retrospective, population-based cohort study using individual patient-level data.

Pearson C. et al, (2026), Lancet Oncol

ssessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials

REITH C. et al, (2026), The Lancet

Substantial variation in the cost of blood group and save and crossmatch: a systematic review

Fabiano G. et al, (2026), British Journal of Haematology

Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trial.

Łaszewska A. et al, (2026), Lancet Reg Health Eur, 61

Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me intervention.

McGeagh L. et al, (2026), Eur J Oncol Nurs, 80

Improving Collaborative Engagement in Health State Valuation: A Scoping Review of Current Practices and Emerging Recommendations.

Powell PA. et al, (2026), Pharmacoeconomics, 44, 141 - 163

Theoretically Universal, Practically Unequal: Socio-Economic Inequalities in Healthcare Access for Long Covid-19 Patients in Austria.

Gamillscheg-Müllner P. et al, (2026), Health Expect, 29

Gabapentin as an adjunct to multimodal pain regimens in surgical patients: the GAP placebo-controlled RCT and economic evaluation.

Baos S. et al, (2026), Health Technol Assess, 30, 1 - 144

On "Inequality in COVID-19 vaccine acceptance and uptake".

Abel ZDV. et al, (2026), Health Policy, 164

Modelled impact of a multi-cancer early detection screening programme on the demand for diagnostics in England

Martin J. et al, (2026), British Journal of Cancer

Load More

1
2
3
4
5
6
7
...
»